- Home
- KALV vs VLGEA Comparison
KALV vs VLGEA Comparison
Compare KALV & VLGEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- VLGEA
- Stock Information
- Founded
- KALV N/A
- VLGEA 1937
- Country
- KALV United States
- VLGEA United States
- Employees
- KALV N/A
- VLGEA N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- VLGEA Food Chains
- Sector
- KALV Health Care
- VLGEA Consumer Staples
- Exchange
- KALV Nasdaq
- VLGEA Nasdaq
- Market Cap
- KALV 651.3M
- VLGEA 532.5M
- IPO Year
- KALV N/A
- VLGEA N/A
- Fundamental
- Price
- KALV $12.92
- VLGEA $38.64
- Analyst Decision
- KALV Strong Buy
- VLGEA
- Analyst Count
- KALV 8
- VLGEA 0
- Target Price
- KALV $24.83
- VLGEA N/A
- AVG Volume (30 Days)
- KALV 498.7K
- VLGEA 34.7K
- Earning Date
- KALV 07-10-2025
- VLGEA 06-10-2025
- Dividend Yield
- KALV N/A
- VLGEA 2.60%
- EPS Growth
- KALV N/A
- VLGEA 3.71
- EPS
- KALV N/A
- VLGEA 3.65
- Revenue
- KALV N/A
- VLGEA $2,281,980,000.00
- Revenue This Year
- KALV N/A
- VLGEA N/A
- Revenue Next Year
- KALV N/A
- VLGEA N/A
- P/E Ratio
- KALV N/A
- VLGEA $10.57
- Revenue Growth
- KALV N/A
- VLGEA 3.96
- 52 Week Low
- KALV $7.30
- VLGEA $24.57
- 52 Week High
- KALV $15.50
- VLGEA $39.17
- Technical
- Relative Strength Index (RSI)
- KALV 60.56
- VLGEA 64.84
- Support Level
- KALV $11.11
- VLGEA $37.65
- Resistance Level
- KALV $11.93
- VLGEA $39.17
- Average True Range (ATR)
- KALV 0.60
- VLGEA 1.05
- MACD
- KALV 0.05
- VLGEA 0.19
- Stochastic Oscillator
- KALV 80.09
- VLGEA 85.75
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About VLGEA Village Super Market Inc.
Village Super Market Inc operates a chain of ShopRite supermarkets, a few of which are in northern New Jersey, southern New Jersey, Maryland, and in northeastern Pennsylvania. The company is a member of Wakefern Food Corporation (Wakefern), a retailer-owned food cooperative and owner of the ShopRite name. It consists of one operating segment, the retail sale of food and nonfood products.